Market Snapshot
S&P Futures
3,819
Dow Futures
30,822
Nasdaq Futures
11,785
HeartBeam, Inc. (BEAT) stock rallied over 2.36% intraday to trade at $1.30 a share on NASDAQ. The stock opened with a gain of 5.69% at $1.36 and touched an intraday high of $1.31, rising 2.36% against the last close of $1.27. The stock went to a low of $1.26 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-07-06 | $1.36 | $1.31 | $1.26 | $1.3 | 53,755 |
2022-07-05 | $1.23 | $1.34 | $1.17 | $1.27 | 67,900 |
2022-07-01 | $1.33 | $1.33 | $1.21 | $1.259 | 11,700 |
2022-06-30 | $1.3 | $1.36 | $1.29 | $1.29 | 59,400 |
2022-06-29 | $1.41 | $1.41 | $1.28 | $1.37 | 62,000 |
2022-06-28 | $1.42 | $1.46 | $1.37 | $1.39 | 21,400 |
2022-06-27 | $1.438 | $1.45 | $1.34 | $1.44 | 39,400 |
2022-06-24 | $1.383 | $1.44 | $1.35 | $1.39 | 59,900 |
2022-06-23 | $1.47 | $1.47 | $1.36 | $1.39 | 9,900 |
2022-06-22 | $1.45 | $1.48 | $1.34 | $1.39 | 19,300 |
Employees-
Beta-
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryHealth Care Equipment
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
HeartBeam, Inc. (NASDAQ: BEAT) stock price is $1.3 as of the last check on Wednesday, July 6. During the trading session, BEAT stock reached the peak price of $1.31 while $1.26 was the lowest point it dropped to.
The NASDAQ listed BEAT is part of Health Care Equipment industry that operates in the broader Health Care sector. HeartBeam, Inc. , a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting.
Dr. Branislav Vajdic Ph.D.
Founder, CEO & Director
Mr. Richard D. Brounstein
Chief Financial Officer
Mr. Richard M. Ferrari
Exec. Chairman
Dr. Branislav Vajdic Ph.D.
Founder, Pres, CEO & Director
BEAT stock traded closed the last session at $1.3, which is $0.03 or 2.36% lower than its previous close of $1.27. BEAT's current trading price is 11.11% lower than its 52-week high of $5.47 where as its distance from 52-week low of 1.17% is -76.23%.
Number of BEAT employees currently stands at -. BEAT operates from 2118 Walsh Avenue, Suite 210, Santa Clara, CA 95050, United States.
Official Webiste of $BEAT is: https://www.heartbeam.com
BEAT could be contacted at BEAT operates from 2118 Walsh Avenue, Suite 210, Santa Clara, CA 95050, United States, or at phone #408 899 4443 and can also be accessed through its website.
BEAT stock volume for the day was 53,755 shares while in the previous session number of BEAT shares traded was 53,755 . The average number of BEAT shares traded daily for last 3 months was 160.39 Thousands.
The percentage change in BEAT stock occurred in the recent session was 2.36% while the dollar amount for the price change in BEAT stock was $0.03.
In the recent session, the day high for BEAT stock was $1.31 while the low for BEAT stock touched on the day was $1.26.
The market value of BEAT currently stands at 10.63 Million with its latest stock price at $1.3 and 8.08 Million of its shares outstanding.